|Articles|October 27, 2022
Boehringer Ingelheim Extends Use of Medidata Rave
Collaboration in EDC renewed for another five years.
Advertisement
Medidata and Boehringer Ingelheim announced a five-year renewal of their collaboration in the area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata.
Read more about the collaboration
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
5